Comparison of human B cell activation by TLR7 and TLR9 agonists

<p>Abstract</p> <p>Background</p> <p>Human B cells and plasmacytoid dendritic cells (pDC) are the only cells known to express both TLR7 and TLR9. Plasmacytoid dendritic cells are the primary IFN-α producing cells in response to TLR7 and TLR9 agonists. The direct effects...

Full description

Bibliographic Details
Main Authors: Neys Lori, Riter Christie L, Vasilakos John P, Hanten John A, Lipson Kenneth E, Alkan Sefik S, Birmachu Woubalem
Format: Article
Language:English
Published: BMC 2008-07-01
Series:BMC Immunology
Online Access:http://www.biomedcentral.com/1471-2172/9/39
_version_ 1818489803684970496
author Neys Lori
Riter Christie L
Vasilakos John P
Hanten John A
Lipson Kenneth E
Alkan Sefik S
Birmachu Woubalem
author_facet Neys Lori
Riter Christie L
Vasilakos John P
Hanten John A
Lipson Kenneth E
Alkan Sefik S
Birmachu Woubalem
author_sort Neys Lori
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Human B cells and plasmacytoid dendritic cells (pDC) are the only cells known to express both TLR7 and TLR9. Plasmacytoid dendritic cells are the primary IFN-α producing cells in response to TLR7 and TLR9 agonists. The direct effects of TLR7 stimulation on human B cells is less understood. The objective of this study was to compare the effects of TLR7 and TLR9 stimulation on human B cell function.</p> <p>Results</p> <p>Gene expression and protein production of cytokines, chemokines, various B cell activation markers, and immunoglobulins were evaluated. Purified human CD19<sup>+ </sup>B cells (99.9%, containing both naïve and memory populations) from peripheral blood were stimulated with a TLR7-selective agonist (852A), TLR7/8 agonist (3M-003), or TLR9 selective agonist CpG ODN (CpG2006). TLR7 and TLR9 agonists similarly modulated the expression of cytokine and chemokine genes (IL-6, MIP1 alpha, MIP1 beta, TNF alpha and LTA), co-stimulatory molecules (CD80, CD40 and CD58), Fc receptors (CD23, CD32), anti-apoptotic genes (BCL2L1), certain transcription factors (MYC, TCFL5), and genes critical for B cell proliferation and differentiation (CD72, IL21R). Both agonists also induced protein expression of the above cytokines and chemokines. Additionally, TLR7 and TLR9 agonists induced the production of IgM and IgG. A TLR8-selective agonist was comparatively ineffective at stimulating purified human B cells.</p> <p>Conclusion</p> <p>These results demonstrate that despite their molecular differences, the TLR7 and TLR9 agonists induce similar genes and proteins in purified human B cells.</p>
first_indexed 2024-12-10T17:08:20Z
format Article
id doaj.art-41d7a15293ec49c7b382a653ad5951c7
institution Directory Open Access Journal
issn 1471-2172
language English
last_indexed 2024-12-10T17:08:20Z
publishDate 2008-07-01
publisher BMC
record_format Article
series BMC Immunology
spelling doaj.art-41d7a15293ec49c7b382a653ad5951c72022-12-22T01:40:24ZengBMCBMC Immunology1471-21722008-07-01913910.1186/1471-2172-9-39Comparison of human B cell activation by TLR7 and TLR9 agonistsNeys LoriRiter Christie LVasilakos John PHanten John ALipson Kenneth EAlkan Sefik SBirmachu Woubalem<p>Abstract</p> <p>Background</p> <p>Human B cells and plasmacytoid dendritic cells (pDC) are the only cells known to express both TLR7 and TLR9. Plasmacytoid dendritic cells are the primary IFN-α producing cells in response to TLR7 and TLR9 agonists. The direct effects of TLR7 stimulation on human B cells is less understood. The objective of this study was to compare the effects of TLR7 and TLR9 stimulation on human B cell function.</p> <p>Results</p> <p>Gene expression and protein production of cytokines, chemokines, various B cell activation markers, and immunoglobulins were evaluated. Purified human CD19<sup>+ </sup>B cells (99.9%, containing both naïve and memory populations) from peripheral blood were stimulated with a TLR7-selective agonist (852A), TLR7/8 agonist (3M-003), or TLR9 selective agonist CpG ODN (CpG2006). TLR7 and TLR9 agonists similarly modulated the expression of cytokine and chemokine genes (IL-6, MIP1 alpha, MIP1 beta, TNF alpha and LTA), co-stimulatory molecules (CD80, CD40 and CD58), Fc receptors (CD23, CD32), anti-apoptotic genes (BCL2L1), certain transcription factors (MYC, TCFL5), and genes critical for B cell proliferation and differentiation (CD72, IL21R). Both agonists also induced protein expression of the above cytokines and chemokines. Additionally, TLR7 and TLR9 agonists induced the production of IgM and IgG. A TLR8-selective agonist was comparatively ineffective at stimulating purified human B cells.</p> <p>Conclusion</p> <p>These results demonstrate that despite their molecular differences, the TLR7 and TLR9 agonists induce similar genes and proteins in purified human B cells.</p>http://www.biomedcentral.com/1471-2172/9/39
spellingShingle Neys Lori
Riter Christie L
Vasilakos John P
Hanten John A
Lipson Kenneth E
Alkan Sefik S
Birmachu Woubalem
Comparison of human B cell activation by TLR7 and TLR9 agonists
BMC Immunology
title Comparison of human B cell activation by TLR7 and TLR9 agonists
title_full Comparison of human B cell activation by TLR7 and TLR9 agonists
title_fullStr Comparison of human B cell activation by TLR7 and TLR9 agonists
title_full_unstemmed Comparison of human B cell activation by TLR7 and TLR9 agonists
title_short Comparison of human B cell activation by TLR7 and TLR9 agonists
title_sort comparison of human b cell activation by tlr7 and tlr9 agonists
url http://www.biomedcentral.com/1471-2172/9/39
work_keys_str_mv AT neyslori comparisonofhumanbcellactivationbytlr7andtlr9agonists
AT riterchristiel comparisonofhumanbcellactivationbytlr7andtlr9agonists
AT vasilakosjohnp comparisonofhumanbcellactivationbytlr7andtlr9agonists
AT hantenjohna comparisonofhumanbcellactivationbytlr7andtlr9agonists
AT lipsonkennethe comparisonofhumanbcellactivationbytlr7andtlr9agonists
AT alkansefiks comparisonofhumanbcellactivationbytlr7andtlr9agonists
AT birmachuwoubalem comparisonofhumanbcellactivationbytlr7andtlr9agonists